SFAM
Springhill Fund Asset Management Portfolio holdings
AUM
$20.9M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$20.9M
AUM Growth
-$40.7M
(-66%)
Holding
30
Top Buys
| 1 | +$2.49M | |
| 2 | +$1.84M | |
| 3 | +$1.79M | |
| 4 |
Neurocrine Biosciences
NBIX
|
+$1.72M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$1.29M |
Top Sells
| 1 | +$6.21M | |
| 2 | +$6.15M | |
| 3 | +$5.56M | |
| 4 |
AstraZeneca
AZN
|
+$5.01M |
| 5 |
Vera Therapeutics
VERA
|
+$4.63M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dyne Therapeutics
DYN
$2.96B
| – | – |
-131,200
|
|
||
27
Legend Biotech
LEGN
$3.46B
| – | – |
-190,800
|
|
||
|
MRUS
28
DELISTED
Merus
MRUS
| – | – |
-83,800
|
|
||
29
Nurix Therapeutics
NRIX
$1.55B
| – | – |
-160,500
|
|
||
|
30
Vera Therapeutics
VERA
$2.85B
| – | – |
-109,400
|
|